Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07190170 · ClinicalTrials.gov registry record · NA
Time Restricted Eating for WeIght LoSs MainTenance-2
A NA study of Weight Loss and Weight Gain, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT07190170: Recruiting NA study of Weight Loss and Weight Gain, sponsored by NYU Langone Health.
NCT07190170 is a NA study of Weight Loss and Weight Gain that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 110 participants, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07190170, a NA study of Weight Loss and Weight Gain, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The TWIST 2.0 Study is a 12-month, 2-arm RCT in adults with recent weight loss. We will examine the efficacy of TRE on weight (Aim 1a) and fat mass (Aim 1b) regain, and describe changes in subjective appetite following a mixed-meal tolerance test (Exploratory).
Conditions Studied
Interventions
- BEHAVIORAL TRE
- BEHAVIORAL Weight-Loss Maintenance Advice
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT07190170 shows while recruiting
NCT07190170 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which TRE is the first listed.
NCT07190170 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07190170 about?
NCT07190170 is a clinical study titled "Time Restricted Eating for WeIght LoSs MainTenance-2". The TWIST 2.0 Study is a 12-month, 2-arm RCT in adults with recent weight loss. We will examine the efficacy of TRE on weight (Aim 1a) and fat mass (Aim 1b) regain, and describe changes in subjective appetite following a mixed-meal tolerance test (Exploratory).
What is the current status of trial NCT07190170?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2025-10-01. Estimated completion is 2028-01-01.
What conditions does trial NCT07190170 study?
This clinical trial studies the following conditions: Weight Loss, Weight Gain, Weight Loss Maintenance.
What interventions are being tested in trial NCT07190170?
The interventions under investigation include: TRE (BEHAVIORAL), Weight-Loss Maintenance Advice (BEHAVIORAL).
Who is sponsoring clinical trial NCT07190170?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07190170 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07190170's enrollment target sits among peer trials
110 43rd of 116 higher than 74 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI